Clinical Research Directory
Browse clinical research sites, groups, and studies.
Letrozole Plus Misoprostol Versus Misoprostol Only in Induction of Missed Abortion
Sponsor: Sohag University
Summary
This study aimed to evaluate the effect of letrozole plus misoprostol to terminate non-viable pregnancies in first trimester compared with the use of misoprostol alone.
Official title: Letrozole Plus Misoprostol Versus Misoprostol Only in Induction of Missed Abortion: A Randomized Controlled Trial
Key Details
Gender
FEMALE
Age Range
18 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
400
Start Date
2025-06-14
Completion Date
2026-03-01
Last Updated
2026-06-09
Healthy Volunteers
No
Interventions
Letrozole + Misoprostol
Patients received 10 mg of Letrozole daily for three days, subsequently receiving 800 µg of Misoprostol every three hours via vaginal or sublingual routes.
Misoprostol
Patients received only 800 µg of Misoprostol.
Locations (1)
Sohag University
Sohag, Egypt